Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mejean

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Urology|May 8, 2000
Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrenceA Mejean, G Vona, B Nalpas, et al.
Analytical Biochemistry|November 14, 1997
Evaluation of cell proliferation through a polymerase chain reaction-based cyclin A testP Paterlini, E Ferrandis, A Mejean, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 26, 2023
Volumetric and functional outcomes at 1-year between percutaneous-ablation and partial-nephrectomy for T1b renal tumorsC Fourniol, C Dariane, J Correas, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 27, 2008
[What may be the waiting time between the diagnosis and surgical treatment of kidney cancer?]Y Neuzillet, J-M Correas, B Escudier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 5, 2012
[Are therapeutics decisions homogeneous in multidisciplinary onco-urology staff meeting? Comparison of therapeutic options taken in four departments from Paris]F Audenet, V Lejay, A Mejean, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 20, 2021
Administration of neoadjuvant chemotherapy for muscle-invasive bladder cancer in real life: Are urologists still too cautious?M Such, A Lavolle, M-B Popelin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 13, 2009
[Atypical cysts and cystic tumours of the kidney: histological, radiological and surgical considerations. Conclusions of the AFU 2007 forum]J-A Long, Y Neuzillet, J-M Correas, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 28, 2018
Nephron sparing surgery in tumours greater than 7cmN de Saint Aubert, F Audenet, F Mccaig, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Treatment of metastatic kidney cancer in elderly subjects]B Escudier, P Paparel, Y Neuzillet, et al.
American Journal of Clinical Pathology|August 10, 1999
Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detectionA Sabile, M Louha, E Bonte, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Urology|May 8, 2000
Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrenceA Mejean, G Vona, B Nalpas, et al.
Analytical Biochemistry|November 14, 1997
Evaluation of cell proliferation through a polymerase chain reaction-based cyclin A testP Paterlini, E Ferrandis, A Mejean, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 26, 2023
Volumetric and functional outcomes at 1-year between percutaneous-ablation and partial-nephrectomy for T1b renal tumorsC Fourniol, C Dariane, J Correas, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 27, 2008
[What may be the waiting time between the diagnosis and surgical treatment of kidney cancer?]Y Neuzillet, J-M Correas, B Escudier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 5, 2012
[Are therapeutics decisions homogeneous in multidisciplinary onco-urology staff meeting? Comparison of therapeutic options taken in four departments from Paris]F Audenet, V Lejay, A Mejean, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 20, 2021
Administration of neoadjuvant chemotherapy for muscle-invasive bladder cancer in real life: Are urologists still too cautious?M Such, A Lavolle, M-B Popelin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 13, 2009
[Atypical cysts and cystic tumours of the kidney: histological, radiological and surgical considerations. Conclusions of the AFU 2007 forum]J-A Long, Y Neuzillet, J-M Correas, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 28, 2018
Nephron sparing surgery in tumours greater than 7cmN de Saint Aubert, F Audenet, F Mccaig, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Treatment of metastatic kidney cancer in elderly subjects]B Escudier, P Paparel, Y Neuzillet, et al.
American Journal of Clinical Pathology|August 10, 1999
Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detectionA Sabile, M Louha, E Bonte, et al.
Pageof 7